| Trade Names: | |
| Synonyms: | |
| Status: | Approved (2015) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| ATC: | C10AX14 |
| UNII: | PP0SHH6V16 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Subtilisin/kexin type 9 inhibitor | DailyMed |
| Primary Target | |
|---|---|
| proprotein convertase subtilisin/kexin type 9 |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Cardiovascular Diseases | 4 | D002318 | ClinicalTrials |
| Hyperlipoproteinemia Type II | 4 | D006938 | ClinicalTrials |
| Coronary Disease | 4 | D003327 | ClinicalTrials |
| Hyperlipoproteinemia Type II | 4 | D006938 | ClinicalTrials |
| Diabetes Mellitus | 3 | D003920 | ClinicalTrials |
| Hypercholesterolemia | 3 | D006937 | ClinicalTrials |
| Lipid Metabolism Disorders | 3 | D052439 | ClinicalTrials |
| Atherosclerosis | 3 | D050197 | ClinicalTrials |
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1245916-14-6 |
| ChEMBL | CHEMBL2109540 |
| FDA SRS | PP0SHH6V16 |
| Guide to Pharmacology | 6744 |
CONTENTS